Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Agilent names Alacris Theranostics as CSP of target enrichment

Agilent Technologies Inc., a manufacturer of measurement instruments and equipment for life sciences, has named Alacris Theranostics GmbH, which is active in the area of next-generation sequencing, or NGS, driven personalized medicine, as an Agilent certified service provider, or CSP, for target enrichment.

Published By MarketLine
22 Jan 2015
NewsWire
NewsWire

IBM announces new technology services agreement with Anthem

International Business Machines Corporation, or IBM, has announced a new strategic technology services agreement with Anthem, Inc., a managed health care company.

Published By MarketLine
22 Jan 2015
NewsWire
NewsWire

Veracyte appoints new board member

Veracyte, Inc., a molecular diagnostics company, has appointed Robert Epstein to its board of directors.

Published By MarketLine
22 Jan 2015
NewsWire
NewsWire

Illumina launches forensic next-generation sequencing system

Illumina, Inc., a provider of sequencing and array-based technologies, has announced the launch of the MiSeq FGx Forensic Genomics System, a forensic next-generation sequencing, or NGS, system, which simultaneously interrogates short tandem repeats, or STR, and other valuable genetic markers, including single nucleotide polymorphisms, or SNPs, to provide informative DNA profiles.

Published By MarketLine
22 Jan 2015
NewsWire
NewsWire

Halozyme appoints new director

Halozyme Therapeutics, Inc., a biopharmaceutical company, has appointed Jean-Pierre Bizzari to its board of directors.

Published By MarketLine
22 Jan 2015
NewsWire
NewsWire

Sucampo appoints new board member

Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, has appointed Robert Spiegel as board member.

Published By MarketLine
22 Jan 2015
NewsWire
NewsWire

UCB receives FDA and EMA acceptance for antiepileptic drug

UCB SA, a biopharmaceutical company, has received the FDA and the EMA acceptance for its investigational antiepileptic drug brivaracetam.

Published By MarketLine
22 Jan 2015
NewsWire
NewsWire

Lansen enters into new distribution agreement for leflunomide tablets in PRC

Lansen Pharmaceutical Holdings Limited, a provider of rheumatic specialty prescription western pharmaceuticals, has announced the non-renewal of an existing distribution agreement and the entering into of a new distribution agreement for leflunomide tablets, a disease modifying anti-rheumatic, or DMARD, product used for the treatment of rheumatoid arthritis, in People's Republic of China, or PRC.

Published By MarketLine
21 Jan 2015
NewsWire
NewsWire

Vectura signs license agreement with Janssen to develop asthma/COPD drug

Vectura Group plc has entered into a global development and license agreement with Janssen Biotech, Inc. for the exclusive development of anti-inflammatory therapies for the treatment of asthma/COPD.

Published By MarketLine
21 Jan 2015
NewsWire
NewsWire

Abaxis receives USDA approval for feline rapid test kit

Abaxis, Inc., a medical products company, has received approval from the Center for Veterinary Biologicals of the US Department of Agriculture, or USDA, for its VetScan FeLV-FIV Rapid Test Kit for the detection of FeLV antigen and FIV antibodies from feline blood samples.

Published By MarketLine
21 Jan 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.